Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, HPV-Unrelated Head and Neck Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial
Clin. Cancer Res 2020 Jul 14;[EPub Ahead of Print], R Uppaluri, KM Campbell, AM Egloff, P Zolkind, ZL Skidmore, B Nussenbaum, RC Paniello, JT Rich, R Jackson, P Pipkorn, LS Michel, J Ley, P Oppelt, GP Dunn, EK Barnell, NC Spies, T Lin, T Li, D Mulder, Y Hanna, I Cirlan, TJ Pugh, T Mudianto, R Riley, L Zhou, VY Jo, MD Stachler, GJ Hanna, JI Kass, RI Haddad, JD Schoenfeld, E Gjini, A Lako, WL Thorstad, HA Gay, M Daly, S Rodig, IS Hagemann, D Kallogjeri, JF Piccirillo, RD Chernock, M Griffith, OL Griffith, DR AdkinsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.